Showing results (4841-4850 of 27,716) with videos related to
Sort By:
Pageof 2,772
Vaccine|September 23, 2015
Spontaneous reports of vasculitis as an adverse event following immunization: A descriptive analysis across three international databasesPatrizia Felicetti, Francesco Trotta, Caterina Bonetto, et al.Vaccine|October 10, 2015
Identification of population at risk for future Clostridium difficile infection following hospital discharge to be targeted for vaccine trialsJames Baggs, Kimberly Yousey-Hindes, Elizabeth Dodds Ashley, et al.Vaccine|September 9, 2015
Conformationally selective biophysical assay for influenza vaccine potency determinationYingxia Wen, Liqun Han, Giuseppe Palladino, et al.Vaccine|September 7, 2015
Relationship between haemagglutination inhibition titre and immunity to influenza in ferretsPaul S Wikramaratna, Andrew RambautVaccine|September 13, 2015
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 18-49 years of age, naive to 23-valent pneumococcal polysaccharide vaccineK A Bryant, R Frenck, A Gurtman, et al.Vaccine|October 16, 2015
Epidemiology of rubella and congenital rubella syndrome in Japan before 1989Kohji UedaVaccine|October 16, 2015
Immune protection-inducing protein structures (IMPIPS) against malaria: the weapons needed for beating OdysseusManuel E Patarroyo, Manuel A Patarroyo, Laura Pabón, et al.Vaccine|October 20, 2015
A role for vector control in dengue vaccine programsRebecca C Christofferson, Christopher N MoresVaccine|October 20, 2015
Correlates of protection of serotype-specific capsular antibody and invasive Group B Streptococcus disease in South African infantsZiyaad Dangor, Gaurav Kwatra, Alane Izu, et al.Vaccine|October 24, 2015
Peptide-specific T helper cells identified by MHC class II tetramers differentiate into several subtypes upon immunization with CAF01 adjuvanted H56 tuberculosis vaccine formulationGennaro Prota, Dennis Christensen, Peter Andersen, et al.Pageof 2,772